Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma.
暂无分享,去创建一个
D. Margolskee | P. Tagari | K. Andersson | D J Margolskee | V C Williams | P Tagari | J B Rasmussen | L O Eriksson | K E Andersson | J. B. Rasmussen | L. Eriksson | V. Williams
[1] D. Margolskee,et al. Urinary LTE4 excretion in antigen‐provoked asthmatic patients treated with the inhaled LTD4 antagonist, L‐648,051 , 1992, Allergy.
[2] P. Tagari,et al. Reduced nonspecific bronchial reactivity and decreased airway response to antigen challenge in atopic asthmatic patients treated with the inhaled leukotriene D4 antagonist, L‐648,051 , 1992, Allergy.
[3] K. Andersson,et al. Reversal and prevention of airway response to antigen challenge by the inhaled leukotriene D4 antagonist (L‐648, 051) in patients with atopic asthma , 1991, Allergy.
[4] W. Abraham,et al. Separation of late bronchial responses from airway hyperresponsiveness in allergic sheep. , 1991, Journal of applied physiology.
[5] J. Hsieh,et al. Interspecies differences in stereoselective protein binding and clearance of MK-571. , 1990, Drug metabolism and disposition: the biological fate of chemicals.
[6] R. Krell,et al. An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways. , 1990, The Journal of pharmacology and experimental therapeutics.
[7] C. Dollery,et al. Leukotriene C4 elimination and metabolism in man. , 1990, The Journal of allergy and clinical immunology.
[8] C T Dollery,et al. Effect of the oral leukotriene D4 antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D4 in atopic subjects. , 1989, The Journal of allergy and clinical immunology.
[9] C. Dollery,et al. URINARY LEUKOTRIENE E4 AFTER ANTIGEN CHALLENGE AND IN ACUTE ASTHMA AND ALLERGIC RHINITIS , 1989, The Lancet.
[10] S. Charleson,et al. Measurement of urinary leukotrienes by reversed-phase liquid chromatography and radioimmunoassay. , 1989, Clinical chemistry.
[11] A. Ford-hutchinson,et al. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. , 1989, Canadian journal of physiology and pharmacology.
[12] S. Dahlén,et al. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.
[13] S P Hanley,et al. The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma. , 1987, The Journal of allergy and clinical immunology.
[14] D. Coursin,et al. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4. , 1986, The Journal of pharmacology and experimental therapeutics.
[15] R. Vessella,et al. Identification and characterization of leukotriene D4 receptors in adult and fetal human lung. , 1985, Biochemical pharmacology.
[16] R. Patterson,et al. The effect of inhaled leukotriene D4 in humans. , 1985, The American review of respiratory disease.
[17] H. Wu,et al. Identification of leukotriene D4 specific binding sites in the membrane preparation isolated from guinea pig lung. , 1984, Prostaglandins.
[18] N. Barnes,et al. Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. , 1984, Thorax.
[19] E. R. Mcfadden,et al. Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy. , 1983, JAMA.
[20] S. Dahlén,et al. Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Shelhamer,et al. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. , 2015, The American review of respiratory disease.
[22] P. Sen,et al. Introduction to bivariate and multivariate analysis , 1981 .
[23] S. Dahlén,et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[24] Bengt Samuelsson,et al. Leukotrienes are potent constrictors of human bronchi , 1980, Nature.
[25] F. Hargreave,et al. Factors in allergen‐induced asthma: relevance of the intensity of the airways allergic reaction and non‐specific bronchial reactivity , 1976, Clinical allergy.
[26] J. Grizzle. THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS. , 1965, Biometrics.
[27] Seymour Geisser,et al. Statistical Principles in Experimental Design , 1963 .